Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG1972-midazolam drug-drug interaction study in healthy male volunteers
NL-OMON44611Phase 1Active, not recruiting
- Sponsor
- Galapagos NV
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GLPG1972 in osteoarthritis (OA), sponsored by Galapagos NV. Primary endpoint: Effect of multiple oral doses of GLPG1972 on single-dose oral midazolam pharmacokinetics. Started Jul 2017; status: active, not recruiting.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON44611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44611.